
11 - 50 employees
Founded 2018
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
Biotechnology • Pharmaceuticals
Belite Bio is a clinical-stage biopharmaceutical company developing novel therapeutics based on its RBP4 (Retinol Binding Protein 4) intellectual property portfolio. Its lead candidate, tinlarebant (LBS-008), is an oral therapy designed to reduce toxic accumulations in the eye and is being developed for retinal degenerative diseases including autosomal recessive Stargardt disease (STGD1) and Geographic Atrophy (advanced dry age-related macular degeneration). Belite Bio is conducting multiple clinical trials (Phase 1b/2, Phase 2/3, and Phase 3 programs such as DRAGON, DRAGON II, and PHOENIX) and tinlarebant has received several regulatory designations (Orphan Drug in US/EU/Japan, Rare Pediatric Disease, Breakthrough Therapy, Fast Track, and Sakigake). The company’s pipeline also includes programs addressing metabolic and liver diseases (e. g. , non-alcoholic fatty liver disease and type 2 diabetes).
🔥 2 minutes ago
Where this job comes from
Posted on Belite Bio's careers page, not through a job board
First seen by Remote Rocketship 2 minutes ago

11 - 50 employees
Founded 2018
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
Biotechnology • Pharmaceuticals
Belite Bio is a clinical-stage biopharmaceutical company developing novel therapeutics based on its RBP4 (Retinol Binding Protein 4) intellectual property portfolio. Its lead candidate, tinlarebant (LBS-008), is an oral therapy designed to reduce toxic accumulations in the eye and is being developed for retinal degenerative diseases including autosomal recessive Stargardt disease (STGD1) and Geographic Atrophy (advanced dry age-related macular degeneration). Belite Bio is conducting multiple clinical trials (Phase 1b/2, Phase 2/3, and Phase 3 programs such as DRAGON, DRAGON II, and PHOENIX) and tinlarebant has received several regulatory designations (Orphan Drug in US/EU/Japan, Rare Pediatric Disease, Breakthrough Therapy, Fast Track, and Sakigake). The company’s pipeline also includes programs addressing metabolic and liver diseases (e. g. , non-alcoholic fatty liver disease and type 2 diabetes).
• Represent Belite as a scientific and technical expert on clinical and research programs and relevant ophthalmology disease areas • Collaborate with medical affairs, clinical development, and commercial teams as a scientific resource to HCPs, payers, and formulary decision makers • Conduct compliant scientific exchange through one-to-one engagement, payer presentations, and Medical Affairs Booth coverage • Respond to and document unsolicited requests for information on Belite clinical and research programs • Develop and execute a KOL engagement plan within the assigned region • Build and maintain long-term collaborative relationships with ophthalmology HCPs and other stakeholders • Provide medical and clinical teams with feedback and insights from HCP interactions • Support employee training, medical materials review and creation, and other scientific projects • Collaborate with US Market Access & Reimbursement and Commercial colleagues on thought leader and institutional engagement • Support launch activities for Belite’s potential first US commercial product in inherited retinal diseases
• Advanced Scientific or Clinical degree (MD, PhD, PharmD) required • 2+ years’ experience in medical affairs strongly preferred • Ophthalmology (preferably retina) experience required • Medical genetics and/or rare disease experience highly desirable • Strong scientific understanding of Ophthalmology, retinal diseases, retinal imaging modalities, and genetic testing • Ability to quickly become a subject matter expert in Belite clinical and research programs • Comfortable presenting clinical data and answering scientific questions from HCPs and payers accurately and compliantly • Demonstrated ability to maintain cross-functional relationships while maintaining appropriate compliance boundaries • Knowledge of the US healthcare and access landscape, specialty pharmacy models, payer dynamics, and the drug-diagnostic interface • Ability to travel frequently within the US, occasionally on weekends • Excellent communication, scientific storytelling, and interpersonal skills • High emotional intelligence and ability to build trust with KOLs and colleagues • Ability to work in a solutions-oriented, adaptable manner in a fast-moving biotech environment • Ability to operate with integrity and compliantly
• Annual incentive bonuses • Equity participation • Health insurance • Dental insurance • Vision insurance • 401(k) • Paid time off
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🔥 5 hours ago
Medical Science Liaison advancing nephrology and immunology care for Otsuka’s pharmaceutical ecosystem. Building clinical partnerships, supporting trials, and delivering evidence-based medical education across Florida and Puerto Rico.
🔥 5 hours ago
Cardiology MSL advancing scientific engagement and medical strategy for MannKind’s cardiometabolic therapies. Supporting KOLs, research initiatives, education, and evidence-based patient care across the North Region.
🇺🇸 United States – Remote
💵 $148k - $222k / year
🔥 Funding within the last year
💰 $50M Post-IPO Equity on 2026-07
⏰ Full Time
🟡 Mid-level
🟠 Senior
🔥 10 hours ago
Field-based Medical Science Liaison advancing Johnson & Johnson’s rheumatology medicines across Ohio. Building scientific partnerships with healthcare professionals and supporting medical affairs strategy.
🔥 12 hours ago
Field-based Rheumatology Medical Science Liaison advancing Johnson & Johnson immunology medicines across Ohio. Building HCP relationships, delivering scientific exchange, and generating medical insights.
🔥 14 hours ago
Field-based Medical Science Liaison advancing Amgen’s rare-disease medicines across Las Vegas and San Diego. Engaging healthcare leaders, providers, payers, and investigators with clinical data.
🇺🇸 United States – Remote
💵 $157k - $212.4k / year
💰 $28.5G Post-IPO Debt on 2022-12
⏰ Full Time
🟡 Mid-level
🟠 Senior
🦅 H1B Visa Sponsor